Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Ming Shing Group Holdings Limited Announces Entering into Strategic Cooperation Framework Agreement with Meal Though Seasons HK Limited

Ming Shing Group Holdings Limited Announces Entering into Strategic Cooperation Framework Agreement with Meal Though Seasons HK Limited

Ming Shing Group Holdings Limited announced it has signed a non-binding strategic cooperation framework agreement with Meal Though Seasons HK Limited. The partnership aims to explore the application of PMA’s graphene thermal management technology in organic agriculture, including temperature control, anti-freezing, low-temperature drying, and cold-…

PN Smart Energy Completes Acquisition of Nanjing Cesun Power, Advancing Its Transition Toward an Independent Power Producer

PN Smart Energy Completes Acquisition of Nanjing Cesun Power, Advancing Its Transition Toward an Independent Power Producer

PN Smart Energy Limited has successfully acquired the remaining 56% equity interest in Nanjing Cesun Power, making it a wholly-owned subsidiary. This acquisition enhances PN Smart's capabilities in photovoltaic development, EPC, and operations, supporting its strategic transition toward becoming a vertically integrated independent power producer sp…

The Elmet Group Co. Schedules Second Quarter 2026 Earnings Call

The Elmet Group Co. Schedules Second Quarter 2026 Earnings Call

The Elmet Group Co., a U.S.-based provider of precision-engineered components and advanced high-energy systems, announced it will hold a conference call on August 13, 2026, to discuss its financial results for the second quarter ended June 30, 2026. The company serves multiple sectors including Aerospace, Defense, Industrial, Medical, Semiconductor…

InterDigital Announces Financial Results for Second Quarter 2026

InterDigital Announces Financial Results for Second Quarter 2026

InterDigital, Inc. reported strong Q2 2026 financial results with annualized recurring revenue reaching a record $626 million, up 13% year-over-year, driven notably by a new streaming and cloud services licensing agreement with Amazon. Despite a decline in GAAP revenue due to reduced catch-up revenue and higher operating expenses related to IP enfo…

Cabot Corporation Announces Planned Leadership Transition

Cabot Corporation Announces Planned Leadership Transition

Cabot Corporation disclosed a leadership transition with President and CEO Sean Keohane retiring effective September 30, 2026. Erica McLaughlin, current Executive Vice President and CFO, will succeed him as President and CEO starting October 1, 2026. Keohane will remain as advisor through the end of 2026 to ensure a smooth leadership transition. Th…

Safe Pro Successfully Completes U.S. Army Project Convergence Capstone 6 Demonstrating AI-Powered Threat Detection and Mapping Capabilities Utilizing Drone-Based Imagery

Safe Pro Successfully Completes U.S. Army Project Convergence Capstone 6 Demonstrating AI-Powered Threat Detection and Mapping Capabilities Utilizing Drone-Based Imagery

Safe Pro Group Inc. successfully completed participation in the U.S. Army's Project Convergence Capstone 6 (PC-C6) exercise, showcasing its AI-powered threat detection and mapping technologies utilizing drone-based imagery. Its NODE-X and OnSight solutions trained soldiers to identify and map explosives and threats on the battlefield, supporting th…

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Celcuity Inc. announced that its FDA-approved drug REVTORPYK (gedatolisib) has been included as a preferred Category 1 second-line or subsequent treatment for HR+/HER2- locally advanced or metastatic breast cancer in the NCCN Clinical Practice Guidelines. REVTORPYK demonstrated significant improvements in progression free survival and response rate…

Lantronix and Swarmer Collaborate to Create Custom Compute Module for Group 1 Unmanned Aerial Systems

Lantronix and Swarmer Collaborate to Create Custom Compute Module for Group 1 Unmanned Aerial Systems

Lantronix Inc. (Nasdaq: LTRX) has partnered with Swarmer Inc. (Nasdaq: SWMR) to develop a custom compute module optimized for Group 1 Unmanned Aerial Systems (UAS). This collaboration aims to deliver an NDAA-compliant, edge AI compute platform with roughly four times the processing power of existing systems, enhancing autonomous drone capabilities …

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial

Clearmind Medicine Inc. announced positive safety and tolerability data from Part A of its FDA-regulated Phase I/II clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate for Alcohol Use Disorder (AUD). The trial successfully completed dose escalation with no serious adverse events, supporting further clinical development …

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

Veru Inc., a NASDAQ-listed late clinical stage biopharmaceutical company, announced its CEO will participate in a fireside chat at the Canaccord Genuity's 46th Annual Growth Investors Conference. The company is advancing its Phase 2b PLATEAU clinical study investigating enobosarm in combination with GLP-1 receptor agonists for improved weight loss …

Cycurion Lands Largest Contract in Company History: $54.6 Million 10-Year Award with Top-5 Global Consulting Firm

Cycurion Lands Largest Contract in Company History: $54.6 Million 10-Year Award with Top-5 Global Consulting Firm

Cycurion, Inc. announced a significant 10-year contract valued at approximately $54.6 million to support the modernization and secure operation of a state government's Health and Human Services System, in partnership with a top-5 global consulting firm. This contract aligns with Cycurion's strategic focus on high-margin, recurring public sector eng…